Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

In this issue

Research

Members of the Northumbria Vanguard team

Impact of an integrated pharmacy service on hospital admission costsSubscription

By , , , , Rachel McWhir, Helen Ridley, , , Robin Hudson, , Jacqueline Ballantyne,

Northumberland was chosen as one of the national vanguard sites in early 2015, in response to the Five year forward view initiative. This article describes the evolution of the integrated pharmacy service, which now operates across organisational boundaries and in collaboration with other healthcare professionals, as well as the improvements in patient care, harm reduction and increased efficiencies achieved using a sustainable model of care.

Finger prick test

Point-of-care C-reactive protein testing in community pharmacy to deliver appropriate interventions in respiratory tract infectionsSubscription

By , ,

This pilot study sought to evaluate the potential use of point-of-care (POC) C-reactive protein (CRP) testing for respiratory tract infections (RTIs) in a rural community pharmacy in North Staffordshire, UK, in conjunction with local GP practices. The study found that the use of POC CRP testing in community pharmacies has the potential to reduce the number of GP appointments caused by RTIs and, therefore, may help reduce unnecessary antibiotic prescribing.

Insight

Illustration of a human foetus illustration

Can omega-3-rich fish oil supplements reduce allergy risk in infants?Subscription

By ,

Results from a meta-analysis show that a mother’s fish oil supplementation during pregnancy may reduce allergy in her children, but the exact benefits of this supplement – and many others – are yet to be determined.

CPD article

PET scan of an epileptic brain

Refractory epilepsy: management in tertiary careSubscription

By

Epilepsy is a neurological disorder marked by sudden recurrent episodes of sensory disturbance, loss of consciousness or convulsions, associated with neurones exhibiting abnormally high electrical excitability in the brain.

Short communications

Understanding cognitive barriers to safer prescribing for frail patientsSubscription

Deciding to stop medicines that have been prescribed in line with clinical guidelines could be seen as counter-cultural. It goes against the grain for clinicians, and often patients, too. This Safer Prescribing for Frailty project used an understanding of the cognitive barriers to stopping medicines to enable general practice teams to design, test and embed ways to better meet the medication needs of their frail populations. We took a comprehensive approach to this assessment using ...

Clinical Pharmacist

cover cp 10 5 18

CP May 2018, Vol 10, No 5

Cover Story:

Point-of-care C-reactive protein testing in community pharmacy to deliver appropriate interventions in respiratory tract infections

Read more…

Clinical Pharmacist

View previous issue

Clinical Pharmacist is a monthly, peer-reviewed journal that provides authoritative resources on the clinical management of disease in relation to medicines and up-to-date information about advances in pharmacy and drug development. Clinical Pharmacist publishes Review articles, Perspectives, evidence-based CPD articles and Research articles on topics from drug discovery to clinical pharmacology and pharmacy.

The international audience of Pharmaceutical Journal Publications consists of pharmacists, pharmaceutical scientists and healthcare professionals. The journal is available to 44,000 members of the Royal Pharmaceutical Society, as well as non-member individual subscribers and subscribing institutions.